Oxford BioMedica Plc (OXB) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Oxford BioMedica plc (Oxford Biomedica) is a gene and cell therapy company that focuses on developing novel treatments for serious diseases. The company along with its subsidiaries has developed LentiVector, a sector leading lentiviral vector delivery platform. It has also built a platform of special cutting-edge technologies and capabilities, based on LentiVector. Based on LentiVector delivery platform Oxford BioMedica has developed a portfolio of gene and cell therapy product candidates in cancer, ophthalmology and central nervous system (CNS) therapy areas. The company also provides lentiviral vector bioprocessing and process development services to partners. Oxford BioMedica is headquartered Oxford, the UK.

Oxford BioMedica Plc (OXB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oxford BioMedica Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Oxford BioMedica Plc, Medical Devices Deals, 2012 to YTD 2018 10
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Oxford BioMedica Acquires Windrush Court Office and Laboratory Facilities for USD5 Million 13
Partnerships 14
Oxford BioMedica Enters into Agreement with Cell Therapy Catapult, Stratophase and Synthace 14
Oxford BioMedica Enters into Agreement with Novartis 15
Oxford BioMedica Enters into Agreement with Green Cross 16
Oxford BioMedica Enters into Agreement with Novartis 17
Licensing Agreements 18
Axovant Sciences Enters into Licensing Agreement with Oxford BioMedica 18
Bioverativ Enters into Licensing Agreement with Oxford BioMedica 20
Orchard Therapeutics Enters into Licensing Agreement with Oxford BioMedica 21
Oxford BioMedica Exercises Option for Licensing Agreement with GlaxoSmithKline 22
Oxford BioMedica Enters into Licensing Agreement with Novartis for LentiVector 23
Oxford BioMedica Amends Licensing Agreement With Sanofi 24
Oxford BioMedica Enters into Licensing Agreement with MolMed 25
Immune Design Licensing Agreement with Oxford BioMedica 26
Equity Offering 27
Oxford BioMedica Raises USD15.3 Million in Private Placement of Shares 27
Oxford BioMedica to Raise USD11.5 Million in Private Placement of Shares 29
Oxford BioMedica Raises USD33 Million in Private Placement of Shares 31
Oxford BioMedica Raises USD2.6 Million in Public Offering 33
Oxford BioMedica Completes Private Placement Of Shares For US$17 Million 34
Oxford BioMedica Completes Rights Offering Of Shares For US$1 Million 35
Oxford BioMedica Plc - Key Competitors 36
Oxford BioMedica Plc - Key Employees 37
Oxford BioMedica Plc - Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Mar 15, 2018: Oxford Biomedica: Preliminary Results for the Year Ended 31 December 2017 39
Aug 17, 2017: Oxford Biomedica: Interim Results For The Six Months Ended 30 June 2017 49
Mar 16, 2017: Oxford Biomedica Announces Preliminary Results for the Year Ended 31 December 2016 54
Corporate Communications 55
Jul 02, 2018: Oxford BioMedica Announces Directorate Change 55
Jun 04, 2018: Oxford BioMedica Announces Directorate Change 56
Mar 15, 2018: Board Change: Oxford BioMedica Appoints Heather Preston as Non-Executive Director 57
Aug 29, 2017: Oxford BioMedica: Stuart Paynter starts as new Chief Financial Officer 58
Feb 28, 2017: Oxford BioMedica Appoints New Chief Financial Officer 59
Government and Public Interest 60
Jan 23, 2018: Oxford BioMedica announces 3 million grant awarded by Innovate UK 60
Other Significant Developments 61
Mar 28, 2018: Gyros Protein Technologies installs two Gyrolab xPlore systems at Oxford BioMedica for gene and cell therapy applications 61
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List Of Tables

List of Tables
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oxford BioMedica Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oxford BioMedica Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Oxford BioMedica Plc, Medical Devices Deals, 2012 to YTD 2018 10
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Oxford BioMedica Acquires Windrush Court Office and Laboratory Facilities for USD5 Million 13
Oxford BioMedica Enters into Agreement with Cell Therapy Catapult, Stratophase and Synthace 14
Oxford BioMedica Enters into Agreement with Novartis 15
Oxford BioMedica Enters into Agreement with Green Cross 16
Oxford BioMedica Enters into Agreement with Novartis 17
Axovant Sciences Enters into Licensing Agreement with Oxford BioMedica 18
Bioverativ Enters into Licensing Agreement with Oxford BioMedica 20
Orchard Therapeutics Enters into Licensing Agreement with Oxford BioMedica 21
Oxford BioMedica Exercises Option for Licensing Agreement with GlaxoSmithKline 22
Oxford BioMedica Enters into Licensing Agreement with Novartis for LentiVector 23
Oxford BioMedica Amends Licensing Agreement With Sanofi 24
Oxford BioMedica Enters into Licensing Agreement with MolMed 25
Immune Design Licensing Agreement with Oxford BioMedica 26
Oxford BioMedica Raises USD15.3 Million in Private Placement of Shares 27
Oxford BioMedica to Raise USD11.5 Million in Private Placement of Shares 29
Oxford BioMedica Raises USD33 Million in Private Placement of Shares 31
Oxford BioMedica Raises USD2.6 Million in Public Offering 33
Oxford BioMedica Completes Private Placement Of Shares For US$17 Million 34
Oxford BioMedica Completes Rights Offering Of Shares For US$1 Million 35
Oxford BioMedica Plc, Key Competitors 36
Oxford BioMedica Plc, Key Employees 37
Oxford BioMedica Plc, Other Locations 38
Oxford BioMedica Plc, Subsidiaries 38

List Of Figures

List of Figures
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Oxford BioMedica Plc, Medical Devices Deals, 2012 to YTD 2018 10

Oxford Pharmascience Group Plc (ABA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxford Pharmascience Group Plc (Oxford Pharmascience) is a drug development company that develops improved formulations of non-steroidal anti-inflammatory drugs and statins. The company offers products such as reduced gastric irritation

USD 250 View Report

University of Oxford - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

University of Oxford - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe University of Oxford Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Oxford BioMedica Plc (OXB) - Financial and Strategic SWOT Analysis Review

Oxford BioMedica Plc (OXB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

OXFORD BIOMEDICA PLC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

OXFORD BIOMEDICA PLC Company Profile is a detailed strategic and analytical report on OXFORD BIOMEDICA PLC. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available